Apparent mineral retention is similar in control and hyperinsulinemic men after consumption of high amylose cornstarch.
The effects on apparent mineral retention after long-term consumption of a high amylose diet containing 30 g resistant starch (RS) were investigated in 10 control and 14 hyperinsulinemic men. Subjects consumed products (bread, muffins, cookies, corn flakes and cheese puffs) made with standard (70% amylopectin, 30% amylose; AP) or high amylose (70% amylose, 30% amylopectin; AM) cornstarch for two 14-wk periods in a crossover pattern. Starch products replaced usual starches in the habitual diet for 10 wk followed by 4 wk of consuming the controlled diets. During wk 12, all urine, feces and duplicate foods were collected for 7 d. Urinary chromium losses after a glucose tolerance test or 24-h collections of the hyperinsulinemic and control subjects did not differ and were not altered by diet. Except for zinc, the two subject types did not differ significantly in apparent mineral balance. Apparent retentions of calcium and magnesium were not significantly affected by diet (AM vs. AP) or type-by-diet interaction. Apparent iron retention tended to be greater after AM than AP consumption (P < 0.09). Apparent copper retention was greater after consuming AP than after AM (P < 0.02), whereas apparent zinc retention was greater after consuming AM than after AP (P < 0.018). Zinc also showed a significant type-by-diet interaction (P < 0.034) with control subjects retaining less zinc after consuming AP than after AM. In summary, a high amylose cornstarch diet containing 30 g RS could be consumed long term without markedly affecting, and possibly enhancing, retention of some minerals.
Behall
Kay M
KM
Diet and Human Performance, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, MD, USA. behall@bhnrc.arsusda.gov
Howe
Juliette C
JC
Anderson
Richard A
RA
D000328:Adult; D000687:Amylopectin / Q000008:administration & dosage / Q000494:pharmacology; D000688:Amylose / Q000008:administration & dosage* / Q000494:pharmacology; D002857:Chromium / Q000652:urine; D004032:Diet; D005951:Glucose Tolerance Test; D006801:Humans; D006946:Hyperinsulinism / Q000378:metabolism* / Q000503:physiopathology; D007501:Iron / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D008903:Minerals / Q000378:metabolism*; D012016:Reference Values; D013213:Starch / Q000737:chemistry*; D013997:Time Factors; D015032:Zinc / Q000378:metabolism
D008903:Minerals; D002857:Chromium; D013213:Starch; D000688:Amylose; D000687:Amylopectin; D007501:Iron; D015032:Zinc